Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
Do you recommend ADT for a high risk prostate cancer patient who had SBRT?
If so, how long?
Answer from: Radiation Oncologist at Community Practice
SBRT doesn’t mitigate benefit of ADT and the type and duration have to be the same as with EBRT or EBRT plus brachytherapy.
Comments
Radiation Oncologist at Genesis Healthcare Partners- San Diego
Since ADT has no benefit in high risk prostate ca ...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
Ma et al., PMID 35934601 This article highlight...
6993
6998
Sign in or Register to read more
Answer from: Radiation Oncologist at Academic Institution
I would not treat a high risk patient with SBRT.
Sign in or Register to read more
14207
14233
Related Questions
Do you still order mpMRI for staging of prostate cancer in addition to PET-PSMA?
How would you treat a patient with retroperitoneal lymphadenopathy that has been biopsy proven metastatic seminoma, who is not a candidate for orchiectomy, RPLND, or systemic therapy?
Would you offer palliative radiation to a patient with hematuria from squamous metaplasia of the bladder that is not responding to endoscopic therapy?
Do you include the prostate when treating bladder cancer?
In what situations would a standard FDG PET/CT be useful in the evaluation of high risk prostate cancer?
For patients undergoing bladder preservation therapy with TMT, how do you manage the urinary urgency and frequency during and after treatment?
What duration androgen deprivation do you recommend with salvage pelvic radiotherapy for pelvic node relapse after prostatectomy?
How do you contour your elective obturator lymph node volume?
When do you consider elective pelvic nodal irradiation for unfavorable intermediate risk prostate cancer?
What is your preferred dose to gross lymph nodes when treating non-metastatic high-risk prostate cancer?
Since ADT has no benefit in high risk prostate ca ...
Ma et al., PMID 35934601 This article highlight...